tiprankstipranks
Apotea AB (SE:APOTEA)
:APOTEA
Sweden Market
Want to see SE:APOTEA full AI Analyst Report?

Apotea AB (APOTEA) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

APOTEA Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Apotea
AB
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

APOTEA Stock 12 Month Forecast

There Are No Analyst Ratings for SE:APOTEA In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

APOTEA Financial Forecast

APOTEA Earnings Forecast

Next quarter’s earnings estimate for APOTEA is kr0.71 with a range of kr0.70 to kr0.72. The previous quarter’s EPS was kr0.79. APOTEA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.89% of the time in the same period. In the last calendar year APOTEA has Performed in-line its overall industry.
Next quarter’s earnings estimate for APOTEA is kr0.71 with a range of kr0.70 to kr0.72. The previous quarter’s EPS was kr0.79. APOTEA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.89% of the time in the same period. In the last calendar year APOTEA has Performed in-line its overall industry.

APOTEA Sales Forecast

Next quarter’s sales forecast for APOTEA is kr1.99B with a range of kr1.97B to kr2.01B. The previous quarter’s sales results were kr2.03B. APOTEA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 53.24% of the time in the same period. In the last calendar year APOTEA has Performed in-line its overall industry.
Next quarter’s sales forecast for APOTEA is kr1.99B with a range of kr1.97B to kr2.01B. The previous quarter’s sales results were kr2.03B. APOTEA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 53.24% of the time in the same period. In the last calendar year APOTEA has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - DeepSeek Analyst forecast on SE:APOTEA
TipRanks - DeepSeek
TipRanks - DeepSeek
kr90kr88
Buy
32.33%
Upside
Reiterated
07/19/26
AI Generated ArticleAI Generated Article
TipRanks - xAI Analyst forecast on SE:APOTEA
TipRanks - xAI
TipRanks - xAI
kr79kr91
Buy
36.84%
Upside
Upgraded
07/18/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on SE:APOTEA
TipRanks - Google
TipRanks - Google
kr78kr91
Buy
36.84%
Upside
Upgraded
07/18/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on SE:APOTEA
OpenAI General EU
TipRanks - OpenAI
Not Ranked
TipRanks - OpenAI
kr77kr87
Buy
30.83%
Upside
Upgraded
07/18/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on SE:APOTEA
TipRanks - Anthropic
TipRanks - Anthropic
kr75kr85
Hold
27.82%
Upside
Reiterated
07/18/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on SE:APOTEA
TipRanks - PerPlexity
TipRanks - PerPlexity
kr81kr90
Buy
35.34%
Upside
Reiterated
07/18/26
AI Generated ArticleAI Generated Article
Analyst Type
Any
Any
AI Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - DeepSeek Analyst forecast on SE:APOTEA
TipRanks - DeepSeek
TipRanks - DeepSeek
kr90kr88
Buy
32.33%
Upside
Reiterated
07/19/26
AI Generated ArticleAI Generated Article
TipRanks - xAI Analyst forecast on SE:APOTEA
TipRanks - xAI
TipRanks - xAI
kr79kr91
Buy
36.84%
Upside
Upgraded
07/18/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on SE:APOTEA
TipRanks - Google
TipRanks - Google
kr78kr91
Buy
36.84%
Upside
Upgraded
07/18/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on SE:APOTEA
OpenAI General EU
TipRanks - OpenAI
Not Ranked
TipRanks - OpenAI
kr77kr87
Buy
30.83%
Upside
Upgraded
07/18/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on SE:APOTEA
TipRanks - Anthropic
TipRanks - Anthropic
kr75kr85
Hold
27.82%
Upside
Reiterated
07/18/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on SE:APOTEA
TipRanks - PerPlexity
TipRanks - PerPlexity
kr81kr90
Buy
35.34%
Upside
Reiterated
07/18/26
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the General Sector
AVEXAEVEX Corp. Class A
GENBGenerate Biomedicines, Inc.
KLRAKailera Therapeutics, Inc.
HMHHMH Holding Inc. Class A
SGPSpyGlass Pharma
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

APOTEA Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, APOTEA has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. APOTEA average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

APOTEA Stock Forecast FAQ

What is SE:APOTEA’s average 12-month price target, according to analysts?
Currently, no data Available
What is SE:APOTEA’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for SE:APOTEA, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Apotea AB a Buy, Sell or Hold?
      Currently, no data Available
      What is Apotea AB’s share price target?
      Currently, no data Available
      What do analysts say about Apotea AB?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Apotea AB?
      To buy shares of SE:APOTEA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.